Published in Clin Cancer Res on January 01, 2001
PPARalpha deficiency in inflammatory cells suppresses tumor growth. PLoS One (2007) 1.24
Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer. Dose Response (2010) 1.16
Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies. Neoplasia (2002) 1.11
Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells. J Clin Invest (2010) 1.09
Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol (2003) 1.08
Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture. Angiogenesis (2010) 1.07
Prognostic value of microvessel density in prostate cancer: a tissue microarray study. World J Urol (2009) 1.03
Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies. Br J Pharmacol (2014) 1.01
Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo. Int J Cancer (2007) 0.99
Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study. Gynecol Oncol (2008) 0.98
Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells. J Exp Clin Cancer Res (2009) 0.94
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer. Gynecol Oncol (2010) 0.92
Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects. Int J Mol Sci (2013) 0.91
Enhanced tumor suppression in vitro and in vivo by co-expression of survivin-specific siRNA and wild-type p53 protein. Cancer Gene Ther (2010) 0.90
Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer. Mol Ther (2012) 0.88
Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-beta activation. Lab Invest (2010) 0.87
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis. Br J Cancer (2014) 0.87
Aberrant expression of DeltaNp73 in benign and malignant tumours of the prostate: correlation with Gleason score. J Clin Pathol (2005) 0.86
Contactin-1 reduces E-cadherin expression via activating AKT in lung cancer. PLoS One (2013) 0.83
Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis. Br J Cancer (2002) 0.82
Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice. PLoS One (2013) 0.80
Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma. Oncotarget (2014) 0.80
Effect of manipulation of primary tumour vascularity on metastasis in an adenocarcinoma model. Br J Cancer (2002) 0.75
Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate. Abdom Imaging (2015) 0.75
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (1999) 9.22
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med (2000) 8.68
Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med (1998) 6.86
Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med (1997) 6.13
LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature (2001) 5.52
Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med (1994) 5.12
The periodic association of MAP2 with brain microtubules in vitro. J Cell Biol (1979) 4.97
Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med (1994) 4.86
Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer (1973) 4.66
Phylogenetic affiliation of the pseudomonads based on 16S rRNA sequence. Int J Syst Evol Microbiol (2000) 4.31
Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J (1994) 4.23
MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell (1996) 4.13
Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. Science (1997) 4.07
Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med (2000) 4.03
Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity. J Histochem Cytochem (1969) 3.91
Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J (1997) 3.74
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci U S A (2001) 3.32
The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci U S A (1996) 3.21
Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res (1999) 2.96
Longitudinal and cross-sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy. Neurology (2009) 2.95
Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell (1997) 2.77
A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. J Exp Med (1996) 2.70
The association of education with coronary heart disease mortality in the USSR Lipid Research Clinics Study. Int J Epidemiol (1993) 2.69
Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes. EMBO J (1999) 2.63
BLNK: a central linker protein in B cell activation. Immunity (1998) 2.59
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet (1997) 2.53
Accuracy of segmental multi-frequency bioelectrical impedance analysis for assessing whole-body and appendicular fat mass and lean soft tissue mass in frail women aged 75 years and older. Eur J Clin Nutr (2013) 2.51
Twisted gastrulation is a conserved extracellular BMP antagonist. Nature (2001) 2.50
Expression of functional acetylcholine receptor from cloned cDNAs. Nature (1984) 2.41
SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity (1998) 2.39
Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation (1995) 2.36
Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J (1995) 2.31
Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst (1996) 2.30
Role of the phospholipase C-inositol 1,4,5-trisphosphate pathway in calcium release-activated calcium current and capacitative calcium entry. J Biol Chem (2001) 2.27
Srg3, a mouse homolog of yeast SWI3, is essential for early embryogenesis and involved in brain development. Mol Cell Biol (2001) 2.26
The relative merits of contemporary measurements and historical calculated fields in the Swedish childhood cancer study. Epidemiology (2000) 2.24
Integration of genetic, clinical, and INR data to refine warfarin dosing. Clin Pharmacol Ther (2010) 2.21
Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest (1997) 2.19
Comparison of propofol and fentanyl administered at the end of anaesthesia for prevention of emergence agitation after sevoflurane anaesthesia in children. Br J Anaesth (2012) 2.15
BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells. Immunity (1999) 2.11
A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature (1994) 2.11
Features of myocardial injury in severe organophosphate poisoning. Clin Toxicol (Phila) (2014) 2.09
Chromosomal aberrations in neuroblastoma cell lines identified by cross species color banding and chromosome painting. Cancer Genet Cytogenet (2001) 2.09
Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J (2000) 2.09
A comparison of human and bovine Escherichia coli O157:H7 isolates by toxin genotype, plasmid profile, and bacteriophage lambda-restriction fragment length polymorphism profile. J Infect Dis (1993) 2.08
Hormone replacement therapy in breast cancer survivors: a cohort study. Am J Obstet Gynecol (1996) 2.04
Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res (1996) 2.04
Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology (2001) 2.00
Molecular cloning and functional characterization of a novel receptor-activated TRP Ca2+ channel from mouse brain. J Biol Chem (1998) 1.90
Bronchial stenosis due to anthracofibrosis. Chest (1998) 1.87
BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity (2000) 1.86
Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol (1999) 1.85
Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors. Hepatology (2000) 1.82
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B. J Clin Oncol (2001) 1.81
Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines. Cancer (1978) 1.77
Health related quality of life differences between black and white men with prostate cancer: data from the cancer of the prostate strategic urologic research endeavor. J Urol (2001) 1.77
Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol (1993) 1.76
Malignant lymphoma, lymphoblastic. Cancer (1976) 1.75
Concern Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill (2015) 1.75
Evaluating RECONSIDER. A computer program for diagnostic prompting. J Med Syst (1985) 1.75
The social course of epilepsy: chronic illness as social experience in interior China. Soc Sci Med (1995) 1.73
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480. Clin Cancer Res (2001) 1.72
Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. Am J Respir Crit Care Med (2000) 1.71
Requirement of phospholipase C-gamma 2 activation in surface immunoglobulin M-induced B cell apoptosis. J Exp Med (1995) 1.71
Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt. J Biol Chem (1999) 1.71
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study. Cancer Res (2001) 1.71
Molecular cloning, expression, and characterization of angiopoietin-related protein. angiopoietin-related protein induces endothelial cell sprouting. J Biol Chem (1999) 1.69
PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model. Allergy (2011) 1.69
Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol Cell Biol (2001) 1.68
Increased susceptibility in Hp knockout mice during acute hemolysis. Blood (1998) 1.68
Per-arnt-sim (PAS) domain-containing protein kinase is downregulated in human islets in type 2 diabetes and regulates glucagon secretion. Diabetologia (2010) 1.67
Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif (2007) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Left ventricular hypertrophy is associated with cerebral microbleeds in hypertensive patients. Neurology (2004) 1.66
A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature (1996) 1.66
Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res (1999) 1.62
Genetic predictors for acute experimental cold and heat pain sensitivity in humans. J Med Genet (2006) 1.62
Staging laparotomies in unselected previously untreated patients with non-Hodgkin's lymphomas. Cancer (1973) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors. Nature (1996) 1.58
Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin Rheumatol (2002) 1.58
Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain. J Exp Med (1992) 1.58
Exposure to air pollution during different gestational phases contributes to risks of low birth weight. Hum Reprod (2003) 1.57
Increased temporolimbic cortical folding complexity in temporal lobe epilepsy. Neurology (2010) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol (1998) 1.55
Formation of vitamin A lipid droplets in pancreatic stellate cells requires albumin. Gut (2009) 1.55
Heterogeneity of microtubule-associated protein 2 during rat brain development. Proc Natl Acad Sci U S A (1984) 1.54
Recovery rate of NTM from AFB smear-positive sputum specimens at a medical centre in South Korea. Int J Tuberc Lung Dis (2005) 1.54
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Cutting edge: essential role of phospholipase C-gamma 2 in B cell development and function. J Immunol (2000) 1.52
Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. Clin Cancer Res (1998) 1.52
B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on Syk kinase. J Immunol (2000) 1.51
Malignant histiocytosis (histiocytic medullary reticulosis). I. Clinicopatholigic study of 29 cases. Cancer (1975) 1.50
Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer (1978) 1.49